Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126028531 | 12602853 | 1 | I | 20160619 | 20160708 | 20160728 | 20160728 | EXP | GB-MHRA-EYC 00141928 | PHHY2016GB094878 | SANDOZ | 65.00 | YR | M | Y | 70.00000 | KG | 20160728 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126028531 | 12602853 | 1 | PS | CLARITHROMYCIN. | CLARITHROMYCIN | 1 | Oral | 500 MG, BID | 3000 | MG | Y | U | N/A | 65136 | 500 | MG | BID | ||
| 126028531 | 12602853 | 2 | C | RENACET | 2 | Unknown | 950 MG, TID | U | 0 | 950 | MG | TID | |||||||
| 126028531 | 12602853 | 3 | C | ALFACALCIDOL | ALFACALCIDOL | 1 | Unknown | 0.5 IU, QD | U | 0 | .5 | IU | QD | ||||||
| 126028531 | 12602853 | 4 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Unknown | 30 MG, QD | U | 0 | 30 | MG | QD | ||||||
| 126028531 | 12602853 | 5 | C | DILTIAZEM. | DILTIAZEM | 1 | Unknown | 180 MG, QD | Y | 0 | 180 | MG | QD | ||||||
| 126028531 | 12602853 | 6 | C | GLICLAZIDE | GLICLAZIDE | 1 | Unknown | 40 MG, QD | Y | 0 | 40 | MG | QD | ||||||
| 126028531 | 12602853 | 7 | C | METRONIDAZOL//METRONIDAZOLE | 2 | Unknown | 400 MG, TID | U | 0 | 400 | MG | TID | |||||||
| 126028531 | 12602853 | 8 | C | ASPIRIN /00346701/ | ASCORBIC ACIDASPIRIN | 1 | Unknown | 75 MG, QD | U | 0 | 75 | MG | QD | ||||||
| 126028531 | 12602853 | 9 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | Y | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126028531 | 12602853 | 1 | Helicobacter infection |
| 126028531 | 12602853 | 2 | Product used for unknown indication |
| 126028531 | 12602853 | 3 | Product used for unknown indication |
| 126028531 | 12602853 | 4 | Product used for unknown indication |
| 126028531 | 12602853 | 5 | Product used for unknown indication |
| 126028531 | 12602853 | 6 | Product used for unknown indication |
| 126028531 | 12602853 | 7 | Product used for unknown indication |
| 126028531 | 12602853 | 8 | Product used for unknown indication |
| 126028531 | 12602853 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126028531 | 12602853 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126028531 | 12602853 | Abdominal distension | |
| 126028531 | 12602853 | Ageusia | |
| 126028531 | 12602853 | Amnesia | |
| 126028531 | 12602853 | Anxiety | |
| 126028531 | 12602853 | Diarrhoea | |
| 126028531 | 12602853 | Dizziness | |
| 126028531 | 12602853 | Drug prescribing error | |
| 126028531 | 12602853 | Flatulence | |
| 126028531 | 12602853 | Hallucination | |
| 126028531 | 12602853 | Insomnia | |
| 126028531 | 12602853 | Logorrhoea | |
| 126028531 | 12602853 | Mydriasis | |
| 126028531 | 12602853 | Tinnitus | |
| 126028531 | 12602853 | Tongue discolouration | |
| 126028531 | 12602853 | Tooth discolouration | |
| 126028531 | 12602853 | Vertigo |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126028531 | 12602853 | 1 | 20160616 | 20160620 | 0 |